Table 1.

Baseline characteristics.

	UC [n = 10]	Non-UC controls [n = 10]
Male/female [%]	5/5 [50/50]	4/6 [40/60]
Median [IQR] age at inclusion [years]	47.3 [33.9–57.6]	58.6 [49.2–70.7]
Median [IQR] age at diagnosis [years]	32 [28–38]	NA
Median [IQR] disease duration [years]	10.5 [4.3–15.3]	NA
Disease activity at inclusiona
Inactive [0–1]	5	NA
Active [2–3]	5	NA
Medication use [%]
5-aminosalicylates	6 [60]	NA
Corticosteroids	1 [10]	NA
Immunomodulators	1 [10]	NA
Biologics	5 [50]	NA
Previous UC-related surgery [%]	0 [0]	NA

UC, ulcerative colitis; IQR, interquartile range; NA, not applicable.

^aDisease activity was based on the overall Mayo endoscopic subscore.